VIVUS, Inc. (NASDAQ: VVUS) announced a new program offering eligible patients a discount on Qsymia (phentermine and topiramate extended-release) capsules ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE